Ming Lu is currently the Director of GCMC China at Pfizer, where they lead the CMC Small Molecule Team and provide regulatory CMC leadership for new product development and marketed products in China. Before joining Pfizer in 2021, Ming held several positions, including Principal Scientist at GlaxoSmithKline and Formulation Group Leader at Roche Pharmaceuticals. Ming earned a Bachelor of Pharmacy and a Doctor of Philosophy in Pharmaceutical Sciences from the University of Bradford. Their extensive experience in pharmaceutical sciences includes leading formulation activities and managing discovery and clinical projects.
This person is not in the org chart
This person is not in any teams
This person is not in any offices